Long-Term Outcomes of Renal Function After Adult Intestinal Transplantation at a Single Small-Volume Center: 2 Cases of Renal Transplantation

2019 ◽  
Vol 51 (5) ◽  
pp. 1525-1530
Author(s):  
Kyung Jai Ko ◽  
Hye Kyung Chang ◽  
Su-Kyung Kwon ◽  
Young Hwa Kim ◽  
Mi-Hyeong Kim ◽  
...  
Keyword(s):  
Renal Function ◽  
Renal Transplantation ◽  
Small Volume ◽  
Intestinal Transplantation ◽  
Long Term Outcomes

Early measurement of interstitial fibrosis predicts long-term renal function and graft survival in renal transplantation

1996 ◽  
Vol 83 (8) ◽  
pp. 1082-1085 ◽  
Author(s):  
M. L. Nicholson ◽  
T. A. McCulloch ◽  
S. J. Harper ◽  
T. J. Wheatley ◽  
C. M. Edwards ◽  
...  
Keyword(s):  
Renal Function ◽  
Renal Transplantation ◽  
Graft Survival ◽  
Interstitial Fibrosis ◽  
Early Measurement

Incidence and long-term outcomes of squamous cell bladder cancer after deceased donor renal transplantation

2013 ◽  
Vol 27 (6) ◽  
pp. E665-E668 ◽  
Author(s):  
N. F. Davis ◽  
L. C. McLoughlin ◽  
C. Dowling ◽  
R. Power ◽  
P. Mohan ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Renal Transplantation ◽  
Squamous Cell ◽  
Deceased Donor ◽  
Long Term Outcomes ◽  
Cell Bladder Cancer

Long Term Outcomes of Renal Transplantation in Infants at a Single Center.

2014 ◽  
Vol 98 ◽  
pp. 498-499
Author(s):  
S. Chinnakotla ◽  
B. Chavers ◽  
K. Gillingham ◽  
P. Verghese ◽  
A. Awode ◽  
...  
Keyword(s):  
Renal Transplantation ◽  
Single Center ◽  
Long Term Outcomes

Revisiting cytomegalovirus serostatus and replication as risk factors for inferior long-term outcomes in the current era of renal transplantation

2020 ◽  
Vol 35 (2) ◽  
pp. 346-356
Author(s):  
Nicole Bischof ◽  
Caroline Wehmeier ◽  
Michael Dickenmann ◽  
Patricia Hirt-Minkowski ◽  
Patrizia Amico ◽  
...  
Keyword(s):  
Risk Factors ◽  
Renal Transplantation ◽  
Patient Survival ◽  
Long Term Outcomes ◽  
Single Centre ◽  
Centre Study ◽  
Single Centre Study ◽  
Cmv Disease ◽  
The Impact

Abstract Background Cytomegalovirus (CMV) serostatus and CMV replication are considered as risk factors for inferior graft and patient survival after renal transplantation, but long-term outcome data are limited. The aim of this retrospective single-centre study was to investigate the impact of CMV serostatus and CMV replication/disease on long-term outcomes in a well-defined cohort managed by a standardized CMV prevention/treatment protocol. Methods We investigated 599 consecutive kidney transplantations having a CMV prevention protocol consisting of either prophylaxis (D+/R− and R+ with ATG induction) or screening/deferred therapy (R+ without ATG induction). Patients were grouped according to CMV serostatus [high risk (D+/R−): n = 122; intermediate risk (R+): n = 306; low risk (D−/R−): n = 171] and occurrence of CMV replication/disease (no CMV replication: n = 419; asymptomatic CMV replication: n = 110; CMV syndrome: n = 39; tissue-invasive CMV disease: n = 31). The median follow-up time was 6.5 years. Results Graft and patient survival were not different among the three CMV serostatus groups as well as the four CMV replication/disease groups (P ≥ 0.44). Eighty-seven patients died, 17 due to infections (21%), but none was attributable to CMV. The overall hospitalization incidence for CMV-related infection was 3% (17/599 patients). The incidence of clinical and (sub)clinical rejection was similar among the groups (P ≥ 0.17). In a multivariate Cox proportional hazard model, neither CMV serostatus, nor CMV replication, nor CMV disease were independent predictors for patient death or graft failure, respectively. Conclusions This retrospective single-centre study suggests that the negative impact of CMV infection on long-term patient and allograft survival as well as on allograft rejection can be largely eliminated with current diagnostic/therapeutic management.

Sign in / Sign up

Export Citation Format

Share Document